Savvy Updates 6/12/23: NovoNordisk Acquires BioCorp, Go Bionic Interview with Stacey Simms, Alexander Zverev Can’t Inject Insulin on Tennis Court, Hyperglycemia, Metformin & Long Covid, KnowLabs Gen1 Prototype, Residual Insulin, Insect-inspired Microphones, Non-Invasive CGMs Just a Dream?

Savvy Updates 6/12/23: NovoNordisk Acquires BioCorp, Go Bionic Interview with Stacey Simms, Alexander Zverev Can’t Inject Insulin on Tennis Court, Hyperglycemia, Metformin & Long Covid, KnowLabs Gen1 Prototype, Residual Insulin, Insect-inspired Microphones, Non-Invasive CGMs Just a Dream?

Novo Nordisk says in talks to acquire French device-maker Biocorp for $165M by Elise Reuter for MedTechDive.com, 5 June 2023. Novo Nordisk wants to innovate faster and develop new connected devices, and expects that Biocorp would complement its internal efforts, said...
Savvy Updates 5/30/23: Metronics Buys Patch Pump EoFlow, Non-Invasive CGM, PIP, The Better Lancet,  Splenda Responds to WHO, Loneliness (and Chat Benches), Impact of Negative Language

Savvy Updates 5/30/23: Metronics Buys Patch Pump EoFlow, Non-Invasive CGM, PIP, The Better Lancet, Splenda Responds to WHO, Loneliness (and Chat Benches), Impact of Negative Language

Medtronic to acquire South Korean wearable insulin patch maker EOFlow by Ravikash for SeekingAlpha.com, 25 May 2023.   Medtronic is acquiring South Korea-based wearable insulin patch maker EOFlow in a deal worth KRW 971B ($738M). The acquisition will...
Savvy Updates, 5/15/23: Know Labs Study, TIR & Young T1Ds & Insulins, Insulin Resistance, Capsule Studies Microbiome, Insulin Temp Stability, Watermelon Heart-Healthy, Embecta/Tidepool Partner for T2D, Glucomate, Diabetes Epidemic in UK, Legislation to Fix Prior Auth

Savvy Updates, 5/15/23: Know Labs Study, TIR & Young T1Ds & Insulins, Insulin Resistance, Capsule Studies Microbiome, Insulin Temp Stability, Watermelon Heart-Healthy, Embecta/Tidepool Partner for T2D, Glucomate, Diabetes Epidemic in UK, Legislation to Fix Prior Auth

Know Labs reports data from feasibility study of Bio-RFID sensor reported on MedicalDevice-Network.com, 8 May 2023. Know Labs has reported data from a new technical feasibility study of its Bio-RFID sensor technology for non-invasive glucose monitoring, compared to...
Savvy Updates 5/1/23:  Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Savvy Updates 5/1/23: Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...
Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?

Savvy Updates 4/24/23: Abbott Libre 3 Reader Cleared, Medtronic MiniMed 780G System Cleared by FDA, Diamyd Precision Medicine Antigen-Specific Immunotherapy, Aspect Biosystems/3D bioprinting, Blackstone Using AI to Control Diabetes, What is Deja Vu?

Abbott gets clearance for Libre 3 reader, opening path to Medicare coverage by Elise Reuter for MedTechDive.com, 17 April 2023.   Since Medicare covers CGMs as durable medical equipment, the devices must include a component, such as a reader, that is...
Skip to content